AtriCure
- Country
- πΊπΈUnited States
- Ownership
- Public
- Established
- 2000-11-01
- Employees
- 1.2K
- Market Cap
- -
- Website
- http://www.atricure.com
- Introduction
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF)
- Conditions
- Persistent Atrial Fibrillation
- Interventions
- Device: AtriCure EPi-Sense-AF Guided Coagulation System with VisiTraxDevice: Endocardial RF Catheter ablation using Open Irrigated-tip RF Abaltion Catheter with unidirectional or bidirectional steering
- First Posted Date
- 2013-11-14
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- AtriCure, Inc.
- Target Recruit Count
- 170
- Registration Number
- NCT01984346
- Locations
- πΊπΈ
East Carolina University - Vidant Medical Center, Greenville, North Carolina, United States
πΊπΈGenesys Regional Medical Center, Grand Blanc, Michigan, United States
πΊπΈHeart Center Research LLC, Huntsville, Alabama, United States
ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation
- Conditions
- Longstanding Persistent Atrial FibrillationPersistent Atrial Fibrillation
- Interventions
- Device: Synergy Ablation System
- First Posted Date
- 2012-09-27
- Last Posted Date
- 2019-10-09
- Lead Sponsor
- AtriCure, Inc.
- Target Recruit Count
- 365
- Registration Number
- NCT01694563
- Locations
- πΊπΈ
USC University Hospital, Los Angeles, California, United States
πΊπΈHartford Hospital, Hartford, Connecticut, United States
πΊπΈWilliam Beaumont Hospital, Royal Oak, Michigan, United States
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
- Conditions
- Atrial Fibrillation
- Interventions
- Device: Ablation procedure staged catheter ablation
- First Posted Date
- 2012-08-09
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- AtriCure, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01661205
- Locations
- π§πͺ
Universitair Ziekenhuis Brussel, Brussel, Belgium
π³π±Academic Medical Center, Amsterdam, Netherlands
πΊπΈStanford University Medical Center, Stanford, California, United States
Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study
- Conditions
- Longstanding Persistent Atrial FibrillationPersistent Atrial Fibrillation
- First Posted Date
- 2010-11-23
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- AtriCure, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01246466
- Locations
- πΊπΈ
Stanford University Medical Center, Stanford, California, United States
πΊπΈVanderbilt Heart Institute, Nashville, Tennessee, United States
πΊπΈBaylor Health, Plano, Texas, United States
AtriCure Bipolar Radiofrequency Ablation of Persistent Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2008-11-05
- Last Posted Date
- 2011-02-21
- Lead Sponsor
- AtriCure, Inc.
- Registration Number
- NCT00785902
AtriCure Exclusion of the LAA in Patients Undergoing Concomitant Cardiac Surgery
- Conditions
- Left Atrial Appendage Exclusion
- Interventions
- Device: AtriCure LAA Exclusion System
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2013-06-04
- Lead Sponsor
- AtriCure, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT00779857
- Locations
- πΊπΈ
St. Francis Heart Hospital, Indianapolis, Indiana, United States
πΊπΈSpectrum Health, Grand Rapids, Michigan, United States
πΊπΈWashington University School of Medicine, St. Louis, Missouri, United States
AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2007-12-12
- Last Posted Date
- 2011-02-21
- Lead Sponsor
- AtriCure, Inc.
- Registration Number
- NCT00571779
Safety and Effectiveness of Left Atrial Appendage Occlusion
- Conditions
- Atrial Fibrillation
- Interventions
- Device: AtriCure LAA Exclusion System
- First Posted Date
- 2007-12-05
- Last Posted Date
- 2013-02-13
- Lead Sponsor
- AtriCure, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT00567515
- Locations
- π¨π
University Hospital of Zurich, Zurich, Switzerland
Concomitant Treatment of Permanent Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2007-12-04
- Last Posted Date
- 2012-01-25
- Lead Sponsor
- AtriCure, Inc.
- Target Recruit Count
- 39
- Registration Number
- NCT00566787
- Locations
- πΊπΈ
Mayo Clinic, Rochester, Minnesota, United States
πΊπΈWashington University, St. Louis, Missouri, United States
πΊπΈHeart Center of Indiana, Indianapolis, Indiana, United States
Sole-Therapy Treatment of Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2007-12-03
- Last Posted Date
- 2013-02-05
- Lead Sponsor
- AtriCure, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT00566176
- Locations
- πΊπΈ
University Community Hospital/Dr. Kiran C. Patel Research Institute, Tampa, Florida, United States
πΊπΈUniversity of Oklahoma Cardiac Arrythmia Research Institute, Oklahoma City, Oklahoma, United States
πΊπΈSacred Heart Medical Center Endovascular Research, Eugene, Oregon, United States